Antibiotic Resistance Research and Stewardship Conference, Virtual, January 26-28, 2021

Pharmacoepidemiologic Evaluation of Echinocandin Use

An Invertebrate Model to Study Clostridioides difficile

ID Week, Virtual, October 21-25, 2020

Inhibitory Effect of Ursodeoxycholic Acid on Clostridioides difficile Growth

Antimicrobial Stewardship Incorporating New Antimicrobials for Use against Multi-Drug Resistant Pseudomonas aeruginosa in Cystic Fibrosis

A Pharmacoepidemiologic Evaluation of Echinocandin Use

An Academic-Information Technology Partnership to Create an Infectious Diseases Translational Science Database

Impact of Revised Infectious Diseases Society of America and Society for Healthcare Epidemiology of America Guideline on the Classification of Clostridioides difficile Infection Severity

Evaluation of Clostridioides difficile Environmental Contamination Surrounding C. difficile Patients vs. non-C. difficile Patients in Outpatient Infusion Centers

A Novel Method to Assess Virulence of Clostridioides difficile: Focus on C. difficile Ribotype 106

Antifungal Resistant Candida glabrata Are Most Commonly Colonized in Clostridioides difficile Infection (CDI) Patient Guts in Texas


ACCP, Virtual, October 19-30, 2020

A Pharmacoepidemiologic Evaluation of Echinocandin Use


Anaerobe, Virtual, July 23-24 2020

Clostridioides difficile Ribotype Distributions Found in the Hospital Environment Versus Clinical Strains

Patients with Severe Clostridioides difficile Infection Have Increased Risk of Systemic Infections with Multidrug-Resistant Organisms  


Antibiotic Resistance Research and Stewardship Conference, Houston, TX, January 22-24, 2020

A Single-Center Surveillance Study of Cystic Fibrosis Microbiological Cultures

Indomethacin Decreases Survival in Clostridioides difficile Infection in an Insect Model, Galleria mellonella

Clinical Outcomes of Ribotype 106 Clostridioides difficile in a Tertiary Hospital

ID Week, Washington DC, October 2-6, 2019

Late Breaker Oral Abstract: (Kevin Garey) A Randomized, Blinded, Placebo- and Vancomycin-Controlled, First-In-Human (FIH) Study of the Safety, Pharmacokinetics (PK), and Fecal Microbiome Effects of ACX-362E, a Novel Anti-Clostridial DNA Polymerase IIIC (polIIIC) Inhibitor

Oral Abstract: (Anne Gonzales-Luna) Clinical Failure Rates Associated with Hemin-induced Metronidazole Resistance in Clostridioides difficile

In vitro Activity of Eravacycline, a New Tetracycline Analog, and Comparators Against the Six Most Commonly Isolated Ribotypes of Clostridioides difficile

Isolation and Characterization of Candida auris From an Active Surveillance System in Texas

Corticosteroid Use Prevents Primary Clostridioides difficile Infection in the Setting of Broad-Spectrum Antibiotic Use Among Hospitalized Patients

Molecular Characteristics of Environmental Clostridioides difficile From a Large Texas Hospital

Effect of Eosinopenia and Binary Toxin on Clostridioides difficile Infection Clinical Outcomes

Clinical Outcomes Associated with an Emerging Clostridioides difficile Ribotype 255 in Texas

Serial Microbiome Analysis in a Patient with Multiple Failed Fecal Microbiome Transplantations 

An Invertebrate Model to Study Gut Microbiome Dysbiosis


Society of Infectious Diseases Pharmacists (SIDP) Annual Meeting, Washington DC, October 1, 2019

Platform Oral Presentation: (Travis Carlson) Eosinopenia and binary toxin increases mortality in hospitalized patients with Clostridioides difficile infection - Travis Carlson


ASM Microbe, San Francisco, California,  June 20-24, 2019

A Retrospective Analysis of Ribotype Distributions Found in the Environment Versus Those Cultured from Clostridioides difficile Infected Patients


ECCMID, Amsterdam, Netherlands, April 13-16, 2019

Texas statewide surveillance of Clostridioides difficile infection, 2011-2018


Antibiotic Resistance Research and Stewardship Conference, Houston, TX, January 23-25, 2019

Epidemiologic surveillance of carbapenem-resistant Enterobacteriaceae in a large academic teaching hospital in Houston, Texas